Choose Your Country or Region

Erenumab (Anti-CALCRL / CGRPR)

Synonyms: null

Catalog No.A2576 Purity:99%

Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Erenumab (Anti-CALCRL / CGRPR)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 7.43mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1582205-90-0
Molecular Weight	145.5 kDa
Isotype	Human IgG2SA
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.

Tags: buy Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) supplier | purchase Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) cost | Erenumab (Anti-CALCRL / CGRPR) manufacturer | order Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) distributor